Browse Category

NASDAQ:PTLE News 4 November 2025

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

Recent News – Earnings Spark a Relief Rally PTL Limited’s latest financial report (released Nov 3, 2025) revealed an unexpected profit, igniting a sharp rally in its beaten-down stock. The Hong Kong–based marine fuel logistics company announced unaudited results for the six months ended June 30, 2025, highlighting a net income of $1.21 million, up from just $0.32 M in the same period a year priorglobenewswire.com. This 277% profit jump came despite revenue falling 13.4% to $43.56 M in H1 2025globenewswire.com. Gross profit was thin at $0.55 M (1.3% margin), down from $1.14 M (2.3% margin) a year agoglobenewswire.com, reflecting razor-thin margins in the bunkering
4 November 2025

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop